MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Integer Holdings Corporation Net Debt 2011-2026 | ITGR
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Integer Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.18 B | 941 M | 945 M | 893 M | 805 M | 653 M | 801 M | 900 M | 1.57 B | 1.63 B | 110 M | 162 M | - | 205 M | 200 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.63 B | 110 M | 785 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-26.7 M | $ 4.3 | -0.69 % | $ 161 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
38.7 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
-12.4 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-77.2 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
-97.8 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-5.12 M | $ 2.29 | -2.97 % | $ 50.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
-3.31 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
6.46 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
3.85 M | $ 11.44 | -2.22 % | $ 324 M | USA |
 |
Apollo Endosurgery
APEN
|
-22.5 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
-5.23 M | $ 1.01 | - | $ 17.1 M | USA |
 |
Alphatec Holdings
ATEC
|
347 M | $ 8.27 | 0.49 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
-32.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
252 K | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
6.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-26.2 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-64.6 M | - | 0.15 % | $ 844 M | USA |
 |
LivaNova PLC
LIVN
|
-282 M | $ 73.83 | 0.26 % | $ 4.03 B |  Britain |
 |
LENSAR
LNSR
|
-10.2 M | $ 6.09 | 2.35 % | $ 72.8 M | USA |
 |
CryoLife, Inc.
CRY
|
230 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
11 M | $ 0.46 | 0.17 % | $ 28.6 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
83.3 M | $ 18.37 | -0.33 % | $ 431 M | USA |
 |
MiMedx Group
MDXG
|
-148 M | $ 3.62 | 0.28 % | $ 535 M | USA |
 |
Delcath Systems
DCTH
|
-42.5 M | $ 11.02 | -3.76 % | $ 395 M | USA |
 |
Soliton, Inc.
SOLY
|
-31.6 M | - | -1.42 % | $ 435 M | USA |
 |
Myomo
MYO
|
-2.42 M | $ 1.04 | 9.47 % | $ 43.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.02 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-2.3 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Pulmonx Corporation
LUNG
|
-31.6 M | $ 1.55 | 0.65 % | $ 63.1 M | USA |
 |
Misonix, Inc.
MSON
|
5.72 M | - | - | $ 462 M | USA |
 |
Orthofix Medical
OFIX
|
78.5 M | $ 10.75 | 3.27 % | $ 426 M |  Curacao |
 |
Neovasc
NVCN
|
-51 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
1.8 M | - | 14.99 % | $ 929 K | USA |
 |
Profound Medical Corp.
PROF
|
-55 M | $ 6.83 | -2.01 % | $ 206 M | Canada |
 |
Electromed
ELMD
|
-10.5 M | $ 38.22 | -0.93 % | $ 323 M | USA |
 |
Butterfly Network
BFLY
|
-130 M | $ 4.47 | -0.22 % | $ 1.1 B | USA |
 |
Intersect ENT, Inc.
XENT
|
50.8 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
2.62 M | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
-898 K | $ 2.39 | 3.91 % | $ 6.63 M | USA |
 |
GBS
GBS
|
-4.38 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
-511 M | $ 84.81 | 0.24 % | $ 11.5 B | USA |
 |
Insulet Corporation
PODD
|
218 M | $ 154.87 | -1.29 % | $ 10.9 B | USA |
 |
CONMED Corporation
CNMD
|
802 M | $ 37.23 | 0.57 % | $ 1.16 B | USA |
 |
Inspire Medical Systems
INSP
|
-433 M | $ 43.84 | -2.01 % | $ 1.29 B | USA |
 |
Invacare Corporation
IVC
|
299 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
-2.32 B | $ 85.78 | 3.1 % | $ 50.2 B | USA |
 |
TransMedics Group
TMDX
|
-32.3 M | $ 68.94 | 0.12 % | $ 2.34 B | USA |